摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氰基-N-环己基-乙酰胺 | 15029-38-6

中文名称
2-氰基-N-环己基-乙酰胺
中文别名
2-氰基-N-环己基乙酰胺
英文名称
2-cyano-N-cyclohexylacetamide
英文别名
Cyanessigsaeure-cyclohexylamid;N-cyclohexylcyanoacetamide
2-氰基-N-环己基-乙酰胺化学式
CAS
15029-38-6
化学式
C9H14N2O
mdl
MFCD00228093
分子量
166.223
InChiKey
RURWLUVLDBYUEN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.777
  • 拓扑面积:
    52.9
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 危险等级:
    IRRITANT
  • 海关编码:
    2926909090

SDS

SDS:b7f5bc117187d751c9b4ab73ce574230
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-氰基-N-环己基-乙酰胺potassium carbonate 作用下, 以 乙醚乙腈 为溶剂, 反应 53.0h, 生成 2-cyano-N-cyclohexyl-2-(2,4-dinitrophenyl)acetamide compound with triethylamine (1:1)
    参考文献:
    名称:
    Synthesis, structural and spectral features of CH-Acids: Amides of 2,4-dinitrophenylcyanoacetic acid and their ammonium salts
    摘要:
    New N-methylmorpholinium and triethylammonium salts of 2,4-dinitrophenylcyanoacetic acid were obtained. Their electronic and spatial structure was studied by IR, NMR spectroscopy (including two-dimensional correlation spectra HMQC and HMBC), as well as by XRD analysis.
    DOI:
    10.1134/s1070363213050137
  • 作为产物:
    描述:
    环己胺氰乙酸盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下, 以 DCM 为溶剂, 反应 24.0h, 以68%的产率得到2-氰基-N-环己基-乙酰胺
    参考文献:
    名称:
    WO2008/99145
    摘要:
    公开号:
点击查看最新优质反应信息

文献信息

  • Synthesis of resveratrol acrylamides derivatives and biological evaluation of their anti-proliferative effect on cancer cell lines
    作者:Ban-Feng Ruan、Si-Qi Wang、Xiao-Lin Ge、Ri-Sheng Yao
    DOI:10.2174/15701808113109990057
    日期:2013.11
    A new series of resveratrol acrylamides amine derivatives was designed, synthesized, and evaluated for their anti-proliferative activity against three cancer cell lines including human chronic myelocytic leukemia cell K562, human hepatoma HuH-7 and human lung carcinoma A549. Most of the compounds showed superior activity against three cell lines when compared to parent resveratrol. C13 had the best anti-tumor activity against the HuH-7 cell line and its IC50 was 4.5 μmol/L; C16 had the best anti-tumor activity against the K562 cell line and its IC50 was 2.9 μmol/L; C18 had the best anti-tumor activity against the A549 cell line and its IC50 was 3.8 μmol/L. It could be seen that the activity of the aromatic amine derivatives was better than the fatty amine derivatives by analyzing the experimental data.
    设计、合成并评价了一系列白藜芦醇丙烯酰胺胺衍生物对三种癌细胞株的抗增殖活性,包括人慢性髓细胞白血病细胞K562、人肝癌HuH-7和人肺癌A549。与母体白藜芦醇相比,大多数化合物对三种细胞株表现出更强的活性。C13对HuH-7细胞株具有最佳的抗肿瘤活性,其IC50为4.5 μmol/L; C16对K562细胞株具有最佳的抗肿瘤活性,其IC50为2.9 μmol/L;C18对A549细胞株具有最佳的抗肿瘤活性,其IC50为3.8 μmol/L。通过分析实验数据可以发现,芳香胺衍生物的活性优于脂肪胺衍生物。
  • Efficient synthesis of new butenolides by subsequent reactions: application for the synthesis of original iminolactones, bis-iminolactones and bis-lactones
    作者:Nawel Cheikh、Nathalie Bar、Nourredine Choukchou-Braham、Bachir Mostefa-Kara、Jean-François Lohier、Jana Sopkova、Didier Villemin
    DOI:10.1016/j.tet.2010.12.062
    日期:2011.2
    We have developed the synthesis of twenty four new iminolactones, bis-iminolactones and bis-lactones by subsequent esterification–condensation or addition–condensation reactions according to two strategies from α-hydroxyketones. The X-ray diffraction data of a bis-iminolactone is described and present an interesting helical column packing.
    根据α-羟基酮的两种策略,我们通过随后的酯化-缩合或加成-缩合反应,开发了二十四种新的亚氨基内酯,双亚氨基内酯和双内酯。描述了双亚氨基内酯的X射线衍射数据,并给出了令人感兴趣的螺旋柱填料。
  • Synthesis and some chemical transformations of novel functionalized 2-imino-2,5-dihydrofurans
    作者:A. A. Avetisyan、L. V. Karapetyan、M. D. Tadevosyan
    DOI:10.1007/s11172-010-0192-2
    日期:2010.5
    Hitherto unknown functionalized 2-imino-3-(N-cyclohexylcarbamoyl)-2,5-dihydrofurans were synthesized by the reactions of tertiary α-hydroxy ketones with N-cyclohexyl(cyano-acetamide). Several reactions of thus synthesized compounds at the imino group were carried out.
    迄今为止未知的官能化 2-亚氨基-3-(N-环己基氨基甲酰基)-2,5-二氢呋喃是通过叔 α-羟基酮与 N-环己基(氰基乙酰胺)的反应合成的。在亚氨基上进行由此合成的化合物的若干反应。
  • A Convenient Synthesis Of Substituted 3-Pyrrolin-2-ones from α-Cetols
    作者:Gaguik Melikian、Francis Rouessac、Christian Alexandre
    DOI:10.1080/00397919308013792
    日期:1993.11
    Abstract A simple and efficient method for the preparation of the title compounds is described from cyanoacetamides and 3-hydroxy-3-methyl-2-butanone in the presence of sodium ethylate at room temperature. The 3-carboxamido-N-alkyl-4, 5, 5-trimethyl-5-dihy dro-2H-pyrrol-2-ones lead to unsaturated derivatives by condensation with aldehydes, while hydrogenation give rise to the corresponding pyrrolidin-2-ones
    摘要 描述了在乙醇钠存在下,在室温下,由氰基乙酰胺和 3-羟基-3-甲基-2-丁酮制备标题化合物的一种简单有效的方法。3-甲酰胺基-N-烷基-4, 5, 5-trimethyl-5-dihy dro-2H-pyrrol-2-ones 通过与醛缩合生成不饱和衍生物,而氢化生成相应的 pyrrolidin-2-ones .
  • Structure–Activity Relationship of SPOP Inhibitors against Kidney Cancer
    作者:Ze Dong、Zhen Wang、Zhong-Qiang Guo、Shouzhe Gong、Tao Zhang、Jiang Liu、Cheng Luo、Hualiang Jiang、Cai-Guang Yang
    DOI:10.1021/acs.jmedchem.0c00161
    日期:2020.5.14
    Previously, we elucidated that the oncogenic SPOP-signaling pathway in ccRCC could be suppressed by 6b that inhibits SPOP-mediated protein interactions. Herein, we have established a structure-activity relationship for 6b analogues as SPOP inhibitors. Compound 6lc suppresses the viability and inhibits the colony formation of ccRCC cell lines driven by cytoplasmic SPOP, superior to 6b. Compound 6lc binds
    在几乎所有的透明细胞肾细胞癌(ccRCC)中,斑点型POZ蛋白(SPOP)在细胞核中过度表达,并在细胞质中错位,从而导致肾脏肿瘤发生。先前,我们阐明了ccRCC中的致癌SPOP信号通路可能被抑制SPOP介导的蛋白质相互作用的6b所抑制。在这里,我们已经建立了6b类似物作为SPOP抑制剂的构效关系。化合物6lc抑制了活力,并抑制了优于6b的细胞质SPOP驱动的ccRCC细胞系的集落形成。化合物6lc在体外与SPOP蛋白结合,并破坏HEK293T细胞中SPOP与磷酸酶和肌腱蛋白同源物(PTEN)的结合,这引起了可观察到的现象:PTEN泛素化的下降,当ccRCC细胞系以剂量反应方式暴露于6lc时,PTEN和双重特异性磷酸酶7的水平升高,磷酸化AKT和ERK的水平降低。两者合计,化合物6lc是对抗肾肿瘤发生的有效候选物。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物